CoreCap Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$593K Sell
8,849
-1,102
-11% -$80.6K 0.02% 504
2026
Q1
$760K Sell
9,951
-1,691
-15% -$122K 0.03% 420
2025
Q4
$743K Sell
11,642
-2,568
-18% -$158K 0.03% 431
2025
Q3
$896K Sell
14,210
-252
-2% -$17.6K 0.03% 397
2025
Q2
$1.08M Buy
14,462
+1,208
+9% +$94.9K 0.04% 336
2025
Q1
$1.17M Buy
13,254
+183
+1% +$17.3K 0.05% 302
2024
Q4
$1.19M Sell
13,071
-2,517
-16% -$258K 0.05% 304
2024
Q3
$1.75M Buy
+15,588
New +$1.56M 0.08% 238
2024
Q2
Sell
-13,462
Closed -$1.35M 1883
2024
Q1
$1.35M Buy
13,462
+623
+5% +$54.8K 0.07% 251
2023
Q4
$1.15M Buy
12,839
+1,345
+12% +$107K 0.07% 233
2023
Q3
$882K Buy
11,494
+562
+5% +$46.6K 0.06% 247
2023
Q2
$915K Buy
+10,932
New +$889K 0.07% 258
2022
Q4
$742K Buy
9,112
+1,543
+20% +$124K 0.05% 283
2022
Q3
$538K Sell
7,569
-99
-1% -$8.9K 0.05% 299
2022
Q2
$688K Sell
7,668
-234
-3% -$24.2K 0.05% 271
2022
Q1
$886K Sell
7,902
-806
-9% -$94.4K 0.06% 242
2021
Q4
$1.05M Buy
+8,708
New +$968K 0.07% 219

Other funds holding EMN

CoreCap Advisors's EMN Position: Q2 2026 in Review

CoreCap Advisors reduced its Eastman Chemical (EMN) stake by 11% in Q2 2026, selling an estimated $80.6K and leaving 8,849 shares worth $593K. The position accounts for 0.02% of the portfolio, ranked #504.

CoreCap Advisors first reported a position in EMN in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.75M in Q3 2024. 75 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • CoreCap Advisors held 8,849 shares of Eastman Chemical worth $593K as of Q2 2026.
  • CoreCap Advisors sold 1,102 Eastman Chemical shares in Q2 2026, an estimated $80.6K.
  • Eastman Chemical made up 0.02% of CoreCap Advisors's portfolio in Q2 2026, its #504 holding.
  • CoreCap Advisors first reported a position in Eastman Chemical in Q4 2021 and has held it in 17 quarters since.
  • CoreCap Advisors's Eastman Chemical position peaked at $1.75M in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.